Benzodiazepine Dependence: Avoidance and Withdrawal
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Benzodiazepine dependence is a frequent complication of regular prescriptions for 4 weeks or longer, occurring in almost one-third of patients. Although it is also manifested by tolerance to drug effects and occasional drug seeking behaviour, particularly in those prone to drug abuse, most dependence is characterised by a withdrawal syndrome on stopping treatment. The withdrawal syndrome includes symptoms of anxiety and those of perceptual disturbance such as depersonalisation, hypersensitivity of all major senses, dysphoria and (rarely) epileptic seizures and psychotic episodes. Risk factors for dependence include high dosage, use of more potent and short acting benzodiazepines, long duration of therapy and dependent premorbid personality characteristics. If none of these apply, benzodiazepines can be prescribed with safety.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They appear more frequently [37, 44, 48] and are more severe [49] with high-potency benzodiazepines with short to medium elimination half-life.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [37]
In the citing paper
“However, even a more flexible tapering at a rate that the patient can tolerate, typically in about 3-6 months, has shown to be appropriate [37].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [37]
In the citing paper
“Dependence develops in almost onethird of patients who are treated with BZDs for ‡4 weeks (173).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [173]
In the citing paper
“Potent BZDs with relatively short t 1 ⁄ 2 (e.g.triazolam, alprazolam and lorazepam) appear to carry the highest risk of dependence (173).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [173]
In the citing paper
“High BZD dosage and potency, short duration of BZD action, long duration of therapy and premorbid dependent personality traits are risk factors for the development of BZD dependence (173).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [173]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610023151403 · Cited by 369
Withdrawal from long-term benzodiazepine treatment
Petursson, H., & Lader, M. H. (1981) · BMJ · doi:10.1136/bmj.283.6292.643 · Cited by 367
Benzodiazepine withdrawal symptoms and propranolol
TYRER, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92861-0 · Cited by 297
Self-citationGradual Withdrawal of Diazepam after Long-Term Therapy
Tyrer, P., Owen, R., & Dawling, S. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92355-3 · Cited by 271
Self-citationBenzodiazepines: a summary of pharmacokinetic properties.
Greenblatt, D., Shader, R., Divoll, M., & Harmatz, J. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01833.x · Cited by 190
The benzodiazepine withdrawal symptom questionnaire
Tyrer, P., Murphy, S., & Riley, P. (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90009-w · Cited by 188
Self-citationCowen, P. J., & Nutt, D. J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90550-5 · Cited by 181
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.7.848 · Cited by 176
Benzodiazepine withdrawal: outcome in 50 patients
ASHTON, H. (1987) · British Journal of Addiction · doi:10.1111/j.1360-0443.1987.tb01529.x · Cited by 160
Winokur, A. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780140103012 · Cited by 156
Cited by
Guidelines for the Rational Use of Benzodiazepines: When and What to Use
Ashton, H. (1994) · Drugs · doi:10.2165/00003495-199448010-00004 · Cited by 593
“anxiety, although some perceptual and motor disturbances may be especially prominent.[1] The management of benzodiazepine withdrawal consists of gradual dosage reduction com-”
BackgroundBenzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
Addiction: Part I. Benzodiazepines--side effects, abuse risk and alternatives.
Longo, L. P., & Johnson, B. (2000) · PubMed · Cited by 420
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Use and Abuse of the Benzodiazepines
Fraser, A. D. (1998) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199810000-00007 · Cited by 243
Metadata
- Authors
- Marriott, S., & Tyrer, P.
- Affiliations
- St Charles Hospital (GB)
- ORCID
- Tyrer, Peter
- Venue
- Drug Safety
- Published
- 1993-08
- Volume
- 9
- Issue
- 2
- Pages
- 93-103
- ISSN
- 0114-5916 (ISSN-L)
- OpenAlex
- W2003054871
- Semantic Scholar
- e42d382623a857b1002fe29176e1e1425a225a45
- Cited by
- 73
- References
- 36
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 3 · 2017: 2 · 2016: 4 · 2015: 2 · 2013: 1 · 2012: 2
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- benzodiazepine dependence, benzodiazepine withdrawal syndrome, drug tolerance, drug-seeking behavior, anxiety, depersonalization, sensory hypersensitivity, dysphoria, epileptic seizures, psychotic episodes, risk factors, benzodiazepine prescribing
- MeSH terms
- Benzodiazepines, Drug Administration Schedule, Drug Tolerance, Humans, Personality, Risk Factors, Substance Withdrawal Syndrome, Anti-Anxiety Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Benzodiazepine Dependence: Avoidance and Withdrawal. https://app.cochat.ai/papers/10.2165/00002018-199309020-00003
- The paper
- Marriott, S., & Tyrer, P. (1993). Benzodiazepine Dependence: Avoidance and Withdrawal. Drug Safety. https://doi.org/10.2165/00002018-199309020-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.